Loading...
TRC is not a good buy right now for an impatient entry. Price is weak (down on the day, hovering just above key support ~16.04) with bearish momentum (MACD histogram negative and expanding). There are no proprietary buy signals today, no near-term news catalysts, and the latest quarter shows revenue growth but a sharp deterioration in profitability (EPS and net income down materially YoY). Net: avoid buying here; if already holding, this setup favors reducing exposure rather than adding.
Trend/Momentum: Bearish-to-neutral. MACD histogram is -0.0209 (below zero) and negatively expanding, signaling increasing downside momentum. RSI(6) ~41 is neutral but leaning weak (not oversold). Moving averages are converging, suggesting a lack of strong trend but with momentum currently tilting down. Levels: Pivot 16.384 overhead; immediate support S1 16.04 (price ~16.09 post-market is sitting just above it). If S1 breaks, next support S2 ~15.827. Resistance levels to reclaim are R1 16.728 then R2 16.94. Pattern/Forward bias: Similar-pattern stats imply modest downside drift (-1.05% 1-week, -1.38% 1-month), which doesn’t support an impatient long entry.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals

Options open interest skew is call-heavy (OI put-call 0.33), suggesting some bullish positioning.
Revenue grew +10.25% YoY in 2025/Q
Upcoming earnings (QDEC
on 2026-02-05 pre-market could act as a catalyst if profitability rebounds.
Momentum weakening: MACD bearish and expanding; price sitting on/near key support (S1 ~16.
increases breakdown risk.
Profitability deterioration in 2025/Q3: net income, EPS, and gross margin all fell sharply YoY.
No recent news/catalysts to reverse the current drift; similar-pattern probabilities point to mild downside over the next week/month.
Very high implied volatility (IV percentile 86.
indicates elevated uncertainty and potentially expensive optionality.
Latest quarter: 2025/Q3. Revenue increased to $11.97M (+10.25% YoY), but profitability weakened significantly: Net income fell to $1.67M (down ~190.96% YoY as reported), EPS fell to $0.06 (down ~185.71% YoY), and gross margin also dropped sharply (as reported). The top-line is growing, but the earnings/margin trend is currently negative, which reduces confidence in an immediate buy.
No analyst rating/price target change data was provided, so a recent Wall Street trend read cannot be confirmed from this dataset. Based on the available fundamentals and technicals here, the pro case would center on land-asset value and revenue growth, while the con case is the clear near-term profitability/margin deterioration and weakening price momentum.
